thyrotab tablett
cp-pharma handelsgesellschaft mbh - naatriumlevotüroksiin - tablett - 200mcg 100tk; 200mcg 30tk
thyrovet tablett
cp-pharma handelsgesellschaft mbh - naatriumlevotüroksiin - tablett - 800mcg 100tk; 800mcg 30tk
thyrovet tablett
cp-pharma handelsgesellschaft mbh - naatriumlevotüroksiin - tablett - 400mcg 250tk; 400mcg 30tk; 400mcg 100tk
thyrovet tablett
cp-pharma handelsgesellschaft mbh - naatriumlevotüroksiin - tablett - 200mcg 100tk; 200mcg 30tk; 200mcg 250tk
thyrotab tablett
cp-pharma handelsgesellschaft mbh - naatriumlevotüroksiin - tablett - 400mcg 100tk; 400mcg 250tk; 400mcg 30tk
thyrotab tablett
cp-pharma handelsgesellschaft mbh - naatriumlevotüroksiin - tablett - 800mcg 100tk
thyrotab tablett
cp-pharma handelsgesellschaft mbh - naatriumlevotüroksiin - tablett - 600mcg 30tk
zavicefta
pfizer ireland pharmaceuticals - avibactam sodium, ceftazidime pentahydrate - pneumonia, bacterial; soft tissue infections; pneumonia; urinary tract infections; gram-negative bacterial infections - antibacterials süsteemseks kasutamiseks, - zavicefta is indicated in adults and paediatric patients aged 3 months and older for the treatment of the following infections:complicated intra-abdominal infection (ciai)complicated urinary tract infection (cuti), including pyelonephritishospital-acquired pneumonia (hap), including ventilator associated pneumonia (vap)treatment of patients with bacteraemia that occurs in association with, or is suspected to be associated with, any of the infections listed above. zavicefta is also indicated for the treatment of infections due to aerobic gram-negative organisms in adults and paediatric patients aged 3 months and older with limited treatment options. tuleks arvesse võtta ametlikke juhiseid sobiva kasutada antibakteriaalseid aineid.
nicopass liquorice mint loseng
pierre fabre medicament - nikotiin - loseng - 1,5mg 36tk; 1,5mg 48tk; 1,5mg 12tk; 1,5mg 24tk; 1,5mg 84tk; 1,5mg 72tk; 1,5mg 204tk; 1,5mg 96tk